Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine
Dengue virus (DENV) comprises four serotypes (DENV1–4) which cause 390 million global infections with 500,000 hospitalizations and 25,000 fatalities annually. Currently, the only FDA approved DENV vaccine is the chimeric live-attenuated vaccine, Dengvaxia®, which is based on the yellow fever virus (...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
Springer
2021
|
| Subjects: | |
| Online Access: | http://eprints.sunway.edu.my/1766/ http://doi.org/10.1007/s00430-021-00700-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|